Unibest
← Back to patent-cliff list

CAS 144809-28-9

(Z)-5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione

Codes: PIOG-013

Application context (from source-drug indications)

Type 2 diabetesAlogliptin Benzoate/Pioglitazone HydrochlorideType 2 diabetesPioglitazone HydrochloridePulmonary hypertensionPioglitazone HydrochlorideBreast cancerPioglitazone HydrochlorideNon-alcoholic steatohepatitisPioglitazone HydrochlorideCocaine addictionPioglitazone HydrochlorideAlcohol abusePioglitazone Hydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
Alogliptin Benzoate/Pioglitazone HydrochlorideTier C — Watch / trade-
Pioglitazone HydrochlorideTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Alogliptin Benzoate/Pioglitazone HydrochlorideOptimised routesteps: 4total yield: 0.65 g
Alogliptin Benzoate/Pioglitazone HydrochlorideOptimised routesteps: 5total yield: 49.60 kg
Pioglitazone HydrochlorideOptimised routesteps: 4total yield: 0.65 g
Pioglitazone HydrochlorideOptimised routesteps: 5total yield: 49.60 kg

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.